Pay in 4 interest-free payments of $5.78 Learn more
Ships within 48 hours · Estimated delivery Oct 30 - Nov 4
Tatsch E, Carvalho JAMD, Hausen BS, Bollick YS, Torbitz VD, Duarte T, et al
Overall prescribing rates (GLP-1 RA prescriptions per total prescriptions) have remained stable in the last 3 months
Addressing and optimizing thyroid function before starting GLP-1 RA therapy is critical in achieving the best possible outcomes
Some patients experience more pronounced nausea, appetite suppression that feels excessive, or GI issues on tirzepatide that do not resolve over time
[2] [11] The American Diabetes Association recommends specific GLP-1 receptor agonists as preferred agents for patients with type 2 diabetes who have established atherosclerotic cardiovascular disease or indicators of high cardiovascular risk
